FIXX - ホモロジ―・メディシンズ (Homology Medicines Inc.) ホモロジ―・メディシンズ

 FIXXのチャート


 FIXXの企業情報

symbol FIxx
会社名 Homology Medicines Inc (ホモロジ―・メディシンズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 医薬品   医療関連(Health Care)
概要 事業概要 Homology Medicines Inc. is a genetic medicines company translating gene editing and gene therapy technology into treatments for patients with rare diseases. The Company is focused on developing a pipeline of new medicines that address and cure the underlying cause of monogenic diseases in the liver central nervous system (CNS) bone marrow lung and the eye. The Company’s lead product candidate HMI-102 is a gene therapy for the treatment of phenylketonuria (PKU). Its PKU program is focused on adults using the gene therapy approach. The Company’s suite of 15 adeno-associated virus vectors (AAVHSCs) enables it to focus on a method of gene editing called gene correction. The Company’s diverse set of AAVHSCs allows it to precisely target via a single intravenous injection a wide range of disease-relevant tissues including the liver central nervous system or CNS bone marrow lung muscle and eye across both modalities - gene editing and gene therapy.   ホモロジ―・メディシンズは米国のバイオ医薬品企業。遺伝病の患者に対する遺伝子医薬品の開発に従事する。同社独自のプラットフォ―ムにより、ヒト造血幹細胞由来のアデノ随伴ウイルスベクタ―を利用して、遺伝子治療や遺伝子編集に取り組む。同社は、単一の疾患遺伝子に起因する一因性疾患に焦点を当てる。本社所在地はマサチュ―セッツ州ベッドフォ―ド。   
本社所在地 45 Wiggins Avenue Bedford MA 01730 USA
代表者氏名 Arthur Tzianabos アーサー・チアナボス
代表者役職名 President Chief Executive Officer Director 社長兼最高経営責任者(CEO)
電話番号 +1 857-305-1825
設立年月日 42064
市場名 NASDAQ National Market System
ipoyear 2018年
従業員数 67人
url www.homologymedicines.com
nasdaq_url https://www.nasdaq.com/symbol/fixx
adr_tso
EBITDA EBITDA(百万ドル) ー
終値(lastsale) 20.02
時価総額(marketcap) 750242472.98
時価総額 時価総額(百万ドル) 746.86980
売上高 売上高(百万ドル) --
企業価値(EV) 企業価値(EV)(百万ドル) 491.36170
当期純利益 当期純利益(百万ドル) --
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Homology Medicines Inc revenues increased from $0K to $1.7M. Net loss increased from $11.6M to $23.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and development - Balancing val increase from $6.8M to $18M (expense) General and administrative - Balancing v increase from $3.8M to $7.7M (expense).

 FIXXのテクニカル分析


 FIXXのニュース

   Alexion, Calyxt, Arvinas: 5 Top Stock Gainers for Monday  2020/12/14 18:36:49 The Street
Alexion Pharmaceuticals, Calyxt, Homology Medicines, Arvinas and SandRidge Energy are five top stock gainers for Monday.
   Homology Medicines News: 9 Things for FIXX Stock Investors to Know About the Pfizer Deal  2020/11/09 15:36:18 InvestorPlace
Homology Medicines (FIXX) is making news on Monday after announcing a massive $60 million investment deal with Pfizer (PFE)
   Homology Medicines Announces $60 Million Equity Investment from Pfizer Inc.  2020/11/09 13:00:00 GlobeNewswire
BEDFORD, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Pfizer Inc….
   Homology Medicines Inc (NASDAQ:FIXX) Receives $30.43 Consensus Price Target from Analysts  2020/10/24 14:37:26 Transcript Daily
Shares of Homology Medicines Inc (NASDAQ:FIXX) have received an average recommendation of “Buy” from the ten research firms that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and seven have given a buy rating to the company. The average […]
   Homology Medicines Inc (NASDAQ:FIXX) Given Consensus Rating of “Buy” by Analysts  2020/10/21 00:22:46 US Banking News
Homology Medicines Inc (NASDAQ:FIXX) has been given an average rating of “Buy” by the ten brokerages that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and seven have assigned a buy rating to the company. The average 1 year price […]
   Alexion, Calyxt, Arvinas: 5 Top Stock Gainers for Monday  2020/12/14 18:36:49 The Street
Alexion Pharmaceuticals, Calyxt, Homology Medicines, Arvinas and SandRidge Energy are five top stock gainers for Monday.
   Homology Medicines News: 9 Things for FIXX Stock Investors to Know About the Pfizer Deal  2020/11/09 15:36:18 InvestorPlace
Homology Medicines (FIXX) is making news on Monday after announcing a massive $60 million investment deal with Pfizer (PFE)
   Homology Medicines Announces $60 Million Equity Investment from Pfizer Inc.  2020/11/09 13:00:00 GlobeNewswire
BEDFORD, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Pfizer Inc….
   Homology Medicines Inc (NASDAQ:FIXX) Receives $30.43 Consensus Price Target from Analysts  2020/10/24 14:37:26 Transcript Daily
Shares of Homology Medicines Inc (NASDAQ:FIXX) have received an average recommendation of “Buy” from the ten research firms that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and seven have given a buy rating to the company. The average […]
   Homology Medicines Inc (NASDAQ:FIXX) Given Consensus Rating of “Buy” by Analysts  2020/10/21 00:22:46 US Banking News
Homology Medicines Inc (NASDAQ:FIXX) has been given an average rating of “Buy” by the ten brokerages that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and seven have assigned a buy rating to the company. The average 1 year price […]
   Alexion, Calyxt, Arvinas: 5 Top Stock Gainers for Monday  2020/12/14 18:36:49 The Street
Alexion Pharmaceuticals, Calyxt, Homology Medicines, Arvinas and SandRidge Energy are five top stock gainers for Monday.
   Homology Medicines News: 9 Things for FIXX Stock Investors to Know About the Pfizer Deal  2020/11/09 15:36:18 InvestorPlace
Homology Medicines (FIXX) is making news on Monday after announcing a massive $60 million investment deal with Pfizer (PFE)
   Homology Medicines Announces $60 Million Equity Investment from Pfizer Inc.  2020/11/09 13:00:00 GlobeNewswire
BEDFORD, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Pfizer Inc….
   Homology Medicines Inc (NASDAQ:FIXX) Receives $30.43 Consensus Price Target from Analysts  2020/10/24 14:37:26 Transcript Daily
Shares of Homology Medicines Inc (NASDAQ:FIXX) have received an average recommendation of “Buy” from the ten research firms that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and seven have given a buy rating to the company. The average […]
   Homology Medicines Inc (NASDAQ:FIXX) Given Consensus Rating of “Buy” by Analysts  2020/10/21 00:22:46 US Banking News
Homology Medicines Inc (NASDAQ:FIXX) has been given an average rating of “Buy” by the ten brokerages that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and seven have assigned a buy rating to the company. The average 1 year price […]

 関連キーワード  (医薬品 米国株 ホモロジ―・メディシンズ FIXX Homology Medicines Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)